C Difficile

9693 bookmarks
Newest
Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI - PubMed
Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI - PubMed
Clostridioides difficile is considered a nosocomial pathogen that flares up in patients exposed to antibiotic treatment. However, four out of ten patients diagnosed with C. difficile infection (CDI) acquired the infection from non-hospitalized individuals, many of whom have not been tr …
·pubmed.ncbi.nlm.nih.gov·
Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI - PubMed
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Non-toxigenic Clostridioides difficile (NTCD) has been shown to decrease the risk of recurrent C. difficile infection (CDI) in patients following metronidazole or vancomycin treatment for CDI. Limited data on the prevalence of NTCD strains in symptomatic patients and their clinical cha …
·pubmed.ncbi.nlm.nih.gov·
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes - PubMed
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes - PubMed
Fecal microbiota transplantation (FMT) is under investigation for several indications, including ulcerative colitis (UC). The clinical success of FMT depends partly on the engraftment of viable bacteria. Because the vast majority of human gut microbiota consists of anaerobes, the currently used aero …
·pubmed.ncbi.nlm.nih.gov·
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes - PubMed
Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease - PubMed
Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease - PubMed
This review explores the potential benefits of fecal microbiota transplantation (FMT) as an adjunct treatment in tuberculosis (TB), drawing parallels from its efficacy in inflammatory bowel disease (IBD). FMT has shown promise in restoring the gut microbial balance and modulating immune responses in …
·pubmed.ncbi.nlm.nih.gov·
Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease - PubMed
Effect of the Administration of a Lyophilised Faecal Capsules on the Intestinal Microbiome of Dogs: A Pilot Study - PubMed
Effect of the Administration of a Lyophilised Faecal Capsules on the Intestinal Microbiome of Dogs: A Pilot Study - PubMed
Faecal Microbiota Transplantation (FMT) is a promising strategy for modulating the gut microbiome. We aimed to assess the effect of the oral administration of capsules containing lyophilised faeces on dogs with diarrhoea for 2 months as well as evaluate their long-term influence on animals' faecal c …
·pubmed.ncbi.nlm.nih.gov·
Effect of the Administration of a Lyophilised Faecal Capsules on the Intestinal Microbiome of Dogs: A Pilot Study - PubMed
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting - PubMed
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting - PubMed
Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host disease. This article aims to review the current …
·pubmed.ncbi.nlm.nih.gov·
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting - PubMed
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target - PubMed
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target - PubMed
Immunotherapy has emerged as an effective treatment for various types of cancers. Recent studies have highlighted a significant correlation between the gut microbiome and patients' response to immunotherapy. Several characteristics of the gut microbiome, such as community structures, taxonomic compo …
·pubmed.ncbi.nlm.nih.gov·
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target - PubMed
Human gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope? - PubMed
Human gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope? - PubMed
Shifts in gut microbiome composition and metabolic disorders are associated with one another. Clinical studies and experimental data suggest a causal relationship, making the gut microbiome an attractive therapeutic goal. Diet, intake of probiotics or prebiotics and faecal microbiome transplantation …
·pubmed.ncbi.nlm.nih.gov·
Human gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope? - PubMed
Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study - PubMed
Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study - PubMed
FMT is an effective treatment for rCDI in patients with CKD. Analysis of the microbiome showed an important intestinal dysbiosis that, besides a significant reduction in Clostridium difficile, did not significantly change after FMT. A trend for reduction was seen in some of the measured URM after FM …
·pubmed.ncbi.nlm.nih.gov·
Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study - PubMed
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Non-toxigenic Clostridioides difficile (NTCD) has been shown to decrease the risk of recurrent C. difficile infection (CDI) in patients following metronidazole or vancomycin treatment for CDI. Limited data on the prevalence of NTCD strains in symptomatic patients and their clinical cha …
·pubmed.ncbi.nlm.nih.gov·
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics - PubMed
Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion Tityus trinitatis with Potent Activity against ESKAPE Pathogens and Clostridioides difficile - PubMed
Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion Tityus trinitatis with Potent Activity against ESKAPE Pathogens and Clostridioides difficile - PubMed
Envenomation by the Trinidad thick-tailed scorpion Tityus trinitatis may result in fatal myocarditis and there is a high incidence of acute pancreatitis among survivors. Peptidomic analysis (reversed-phase HPLC followed by MALDI-TOF mass spectrometry and automated Edman degradation) of T. …
·pubmed.ncbi.nlm.nih.gov·
Identification of an Antimicrobial Peptide from the Venom of the Trinidad Thick-Tailed Scorpion Tityus trinitatis with Potent Activity against ESKAPE Pathogens and Clostridioides difficile - PubMed
Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach - PubMed
Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach - PubMed
Molecular mimicry, a phenomenon in which microbial or environmental antigens resemble host antigens, has been proposed as a potential trigger for autoimmune responses. In this study, we employed a bioinformatics approach to investigate the role of molecular mimicry in Clostridioides difficile …
·pubmed.ncbi.nlm.nih.gov·
Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach - PubMed
Association of Clostridioides difficile infection rates with social determinants of health in Denver area census tracts, 2016-2019 - PubMed
Association of Clostridioides difficile infection rates with social determinants of health in Denver area census tracts, 2016-2019 - PubMed
We evaluated the association between census tract measures of socioeconomic status and Clostridioides difficile infection (CDI) rates in the Denver metro area from 2016 to 2019. Social vulnerability index, poverty, and race were associated with CDI. Findings may relate to differences in chron …
·pubmed.ncbi.nlm.nih.gov·
Association of Clostridioides difficile infection rates with social determinants of health in Denver area census tracts, 2016-2019 - PubMed
One size does not fit all - Trehalose metabolism by Clostridioides difficile is variable across the five phylogenetic lineages - PubMed
One size does not fit all - Trehalose metabolism by Clostridioides difficile is variable across the five phylogenetic lineages - PubMed
Clostridioides difficile, the leading cause of antibiotic-associated diarrhoea worldwide, is a genetically diverse species which can metabolise a number of nutrient sources upon colonising a dysbiotic gut environment. Trehalose, a disaccharide sugar consisting of two glucose molecules bonded …
·pubmed.ncbi.nlm.nih.gov·
One size does not fit all - Trehalose metabolism by Clostridioides difficile is variable across the five phylogenetic lineages - PubMed
Clostridioides Difficile in Latin America: An Epidemiological Overview - PubMed
Clostridioides Difficile in Latin America: An Epidemiological Overview - PubMed
Clostridioides difficile infection is one of the most significant causes of nosocomial diarrhea associated with antibiotic use worldwide. In recent years, the incidence of Clostridioides difficile infection in Latin American countries has increased due to the emergence and spread of epidemic Clostri …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides Difficile in Latin America: An Epidemiological Overview - PubMed
2 Antibiotics Show Similar Efficacy for Healthcare-Associated Infection
2 Antibiotics Show Similar Efficacy for Healthcare-Associated Infection
Patients treated with oral metronidazole experienced significantly more first-line drug changes compared to those on fidaxomicin; although there were no significant differences observed in the global or clinical cure rate between the 2 treatments.
·contagionlive.com·
2 Antibiotics Show Similar Efficacy for Healthcare-Associated Infection
A computational method to dissect colonization resistance of the gut microbiota against pathogens - PubMed
A computational method to dissect colonization resistance of the gut microbiota against pathogens - PubMed
The mammalian gut microbiome protects the host through colonization resistance (CR) against the incursion of exogenous and often harmful microorganisms, but identifying the exact microbes responsible for the gut microbiota-mediated CR against a particular pathogen remains a challenge. To address thi …
·pubmed.ncbi.nlm.nih.gov·
A computational method to dissect colonization resistance of the gut microbiota against pathogens - PubMed
C. difficile Infection Therapeutic Drug Market Growth Analysis by Size and Share 2023 | Opportunities, Market Dynamics and Forecast to 2030 | with 122 Pages
C. difficile Infection Therapeutic Drug Market Growth Analysis by Size and Share 2023 | Opportunities, Market Dynamics and Forecast to 2030 | with 122 Pages
The research report on the global "C. difficile Infection Therapeutic Drug Market" for 2023 includes an overview of the market, market dynamics, segmentation (by type, application, end user, and region), the most recent
·news.google.com·
C. difficile Infection Therapeutic Drug Market Growth Analysis by Size and Share 2023 | Opportunities, Market Dynamics and Forecast to 2030 | with 122 Pages
Multipronged Approach: Reducing Clostridioides Difficile Infections in Hospitals
Multipronged Approach: Reducing Clostridioides Difficile Infections in Hospitals
The following is a summary of “Impact of a multipronged approach to reduce the incidence of Clostridioides difficile infections in hospitalized patients,” published in the June 2023 issue of Infection Control by Katzman et al. The objective is to reduce Clostridioides difficile infections (CDI) in hospitalized patients, effective strategies are required. Researchers report data from
·news.google.com·
Multipronged Approach: Reducing Clostridioides Difficile Infections in Hospitals
Identification of antibiotic consumption targets for the management of clostridioides difficile infection in hospitals- a threshold logistic modeling approach - PubMed
Identification of antibiotic consumption targets for the management of clostridioides difficile infection in hospitals- a threshold logistic modeling approach - PubMed
Using threshold logistic analysis, critical incidence levels and antibiotic use targets to control HOHA CDI were determined. Threshold logistic models can be used to inform and enhance the effective design and implementation of antimicrobial stewardship programs.
·pubmed.ncbi.nlm.nih.gov·
Identification of antibiotic consumption targets for the management of clostridioides difficile infection in hospitals- a threshold logistic modeling approach - PubMed
Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin - PubMed
Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin - PubMed
Clostridioides difficile is a leading cause of antibiotic-associated diarrheal disease. C. difficile colonization, growth, and toxin production in the intestine is strongly associated with its ability to use amino acids to generate energy, but little is known about the impact of specif …
·pubmed.ncbi.nlm.nih.gov·
Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin - PubMed
Correlating Antibiotic-Induced Dysbiosis to Clostridioides difficile Spore Germination and Host Susceptibility to Infection Using an Ex Vivo Assay - PubMed
Correlating Antibiotic-Induced Dysbiosis to Clostridioides difficile Spore Germination and Host Susceptibility to Infection Using an Ex Vivo Assay - PubMed
Antibiotic-induced microbiota disruption and its persistence create conditions for dysbiosis and colonization by opportunistic pathogens, such as those causing Clostridioides difficile (C. difficile) infection (CDI), which is the most severe hospital-acquired intestinal infection. Give …
·pubmed.ncbi.nlm.nih.gov·
Correlating Antibiotic-Induced Dysbiosis to Clostridioides difficile Spore Germination and Host Susceptibility to Infection Using an Ex Vivo Assay - PubMed
Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection? - PubMed
Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection? - PubMed
Allowing bedside nurses more autonomy to order the stool sample significantly decreased the amount of time to receive the results, potentially decreasing the risk of additional infections among patients and decreasing the economic burden on the hospital.
·pubmed.ncbi.nlm.nih.gov·
Does clinician-initiated Clostridioides difficile testing improve outcomes of patients with Clostridioides Difficile infection? - PubMed
Trial in Elderly with Musculoskeletal Problems due to Underlying Sarcopenia-Faeces to Unravel the Gut and Inflammation Translationally (TEMPUS-FUGIT): protocol of a cross-sequential study to explore the gut-muscle axis in the development and treatment of sarcopenia in community-dwelling older adults - PubMed
Trial in Elderly with Musculoskeletal Problems due to Underlying Sarcopenia-Faeces to Unravel the Gut and Inflammation Translationally (TEMPUS-FUGIT): protocol of a cross-sequential study to explore the gut-muscle axis in the development and treatment of sarcopenia in community-dwelling older adults - PubMed
ClinicalTrails.gov NCT05008770, registered on August 17, 2021; first participant enrolled on September 21 2021.
·pubmed.ncbi.nlm.nih.gov·
Trial in Elderly with Musculoskeletal Problems due to Underlying Sarcopenia-Faeces to Unravel the Gut and Inflammation Translationally (TEMPUS-FUGIT): protocol of a cross-sequential study to explore the gut-muscle axis in the development and treatment of sarcopenia in community-dwelling older adults - PubMed
Pushing the frontiers in the fight against antimicrobial resistance: the potential of fecal and maggot therapies - PubMed
Pushing the frontiers in the fight against antimicrobial resistance: the potential of fecal and maggot therapies - PubMed
The escalating crisis of antimicrobial resistance (AMR) warrants innovative therapeutic strategies. Fecal microbiota transplantation (FMT) and maggot debridement therapy (MDT) represent paradigm-shifting approaches, leveraging biological systems to mitigate AMR. FMT restores a healthy gut microbiome …
·pubmed.ncbi.nlm.nih.gov·
Pushing the frontiers in the fight against antimicrobial resistance: the potential of fecal and maggot therapies - PubMed